remoxipride has been researched along with Schizophrenia in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (15.28) | 18.7374 |
1990's | 60 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (1.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Subramanian, S | 1 |
Kerwin, R | 1 |
Kane, JM | 1 |
Kerwin, RW | 1 |
Bryois, C | 1 |
Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP | 1 |
Aravagiri, M; Marder, SR; Midha, KK; Van Putten, T | 1 |
Burnett, P; Burrows, G; Catts, S; George, T; Hustig, H; Keks, N; Lambert, T; McGrath, J; Vaddadi, K; Varghese, F | 1 |
King, DJ | 1 |
Evenden, J; Jackson, DM; Mohell, N; Ryan, C | 1 |
Lewander, T | 2 |
Conley, R; Nguyen, JA; Tamminga, CA | 1 |
Klieser, E; Lemmer, W; Strauss, WH | 1 |
Eriksson, L | 1 |
Monnet, FP | 1 |
Goldman-Rakic, PS; Lidow, MS | 1 |
Edsman, I; Holm, AC; Lundberg, T; Odlind, B | 1 |
Hagert, U; Lang, S; Leinonen, E; Putkonen, A; Tolvanen, U; Vartiainen, H | 1 |
Chang, WH; Chien, CP; Jann, MW; Lam, YW; Lin, SK | 1 |
Liu, KL; Lung, FW | 1 |
Angus, C; Awad, AG; Lapierre, YD; Rylander, A | 1 |
Laor, N; Toren, P; Weizman, A | 1 |
Angus, C; Awad, AG; Busse, E; Carle, R; Claesson, L; Denis, JF; Gauthier, B; Grafford, K; Jones, B; Labelle, A; Lapierre, YD; Lavallee, YJ; Malla, AK; Manchanda, R; Oyewumi, LK; Saxena, BM; Teehan, MD; Vincent, P; Williamson, P; Wolf, MA | 1 |
Boulay, LJ; Labelle, A; Lapierre, YD | 1 |
Blomqvist, M; Cooper, SJ; Doherty, MM; King, DJ; Mitchell, MJ; Montgomery, RC | 1 |
Ancill, R; Awad, G; Bakish, D; Beaudry, P; Bloom, D; Chandrasena, R; Das, M; Durand, C; Elliott, D; Lapierre, YD | 1 |
Amman, J; Beckmann, H; Bunse, J; Eikmeier, G; Geretsegger, C; Hebenstreit, GF; Kanitz, RD; Kanzow, WT; Laux, G; Schubert, H | 1 |
Appelberg, B; Katila, H; Kuoppasalmi, K; Lahdelma, RL; Rimón, R | 1 |
Gerlach, J | 1 |
Ashwood, T; Movin, G; Soni, SD; Tench, D | 1 |
den Boer, JA; Westenberg, HG | 1 |
Franzén, G; Jansson, P; Movin, G; Widerlöv, E | 1 |
Den Boer, JA; Huisman, J; Ohrvik, J; Ravelli, DP; Verhoeven, WM; Westenberg, HG | 2 |
Kleinerman, MJ | 1 |
Andersen, J; Birket-Smith, M; Fensbo, C; Fogh, M; Hansen, NR; Kristensen, M; Kørner, A; Møller-Nielsen, EM; Ostergaard, P; Thiesen, S | 1 |
Chouinard, G | 2 |
Chanas, A; Deo, R; Edwards, JG; Levine, S; Mitchell, M; Plant, I; Rastogi, SC; Soni, S | 1 |
Beckmann, H; Bunse, J; Dittmann, V; Klieser, E; König, P; Laux, G; Schöny, HW; Schröder, HG; Schubert, H; Unterweger, B | 1 |
Akselson, S; Andersen, T; Arthur, H; Kristjansson, E; Lindgren, S; Lindström, LH; Naimell, L; Norman, O; Struwe, G; Wieselgren, IM | 1 |
Crocket, G; Eccleston, D; Herrington, RN; Huitfeldt, B; Livingston, M; McCreadie, RG; Mitchell, MJ; Tait, D; Todd, N; Watt, JA | 1 |
Cosyns, P; de Bleeker, E; Deleu, G; Lotstra, F; Masson, A; Mendlewicz, J; Mertens, C; Parent, M; Peuskens, J; Suy, E | 1 |
Bartels, M; Bauer, H; Bunse, J; Gallhofer, B; Haas, S; Kanzow, WT; Klieser, E; Küfferle, B; Pflug, B; Stein, D | 1 |
Holm, AC; Wålinder, J | 1 |
Englund, A; Lawrie, V; Lewander, T; Morrison, D; Schlachet, A; Westerbergh, SE | 1 |
Franzén, G; Gustafson, L; Movin, G; Nilsson, L; Soni, SD; Tench, D; Widerlöv, E; Yisak, W | 1 |
Ashwood, TJ; Movin, G; Soni, SD; Tench, D | 1 |
Jostell, KG; Lapierre, YD | 1 |
Albaret, C; Kahn, JP; Laxenaire, M; Nilsson, L; Yisak, W; Zaar-Hedin, A | 1 |
Klieser, E; Strauss, WH | 1 |
Farde, L; von Bahr, C | 1 |
Sedvall, G | 1 |
Awad, AG; Bakish, D; Chouinard, G; Jones, B; Lapierre, YD; Manchanda, R; Max, P; McClure, DJ; Nair, NP; Saxena, B | 1 |
Agussol, P; Alby, JM; Brion, S; Burnat, G; Castelnau, D; Deluermoz, S; Dufour, H; Ferreri, M; Goudemand, M; Patris, M | 1 |
Lewander, T; Morrison, D; Westerbergh, SE | 1 |
Ahlfors, UG; Appelberg, B; Hagert, U; Harma, P; Katila, H; Mahlanen, A; Mehtonen, OP; Naukkarinen, H; Outakoski, J; Rimön, R | 1 |
Heel, RC; Wadworth, AN | 1 |
Anderer, P; Grünberger, J; Küfferle, B; Saletu, B; Steinberger, K | 1 |
Awad, AG; Jostell, KG; Lapierre, YD | 1 |
Classen, W; Laux, G | 1 |
Largent, BL; Snyder, SH | 1 |
Besev, G; Lindström, L; Stening, G; Widerlöv, E | 1 |
Eccleston, D; Gall, RG; Loudon, J; McCreadie, RG; Mitchell, MJ; Morrison, D | 1 |
Chouinard, G; Kallai-Sanfacon, MA; Turnier, L | 1 |
Chouinard, G; Turnier, L | 1 |
den Boer, JA; Verhoeven, WM; Westenberg, HG | 2 |
Gerlach, J; Lund Laursen, A | 1 |
Crocket, G; Eccleston, D; Huitfeldt, B; Livingston, M; McCreadie, RG; Mitchell, MJ; Tait, D; Todd, N; Watt, JA | 1 |
13 review(s) available for remoxipride and Schizophrenia
Article | Year |
---|---|
Zotepine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Dibenzothiepins; Humans; Randomized Controlled Trials as Topic; Remoxipride; Risperidone; Schizophrenia | 2010 |
Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.
Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia; Treatment Outcome | 1993 |
The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
Topics: Antipsychotic Agents; Brain; Clozapine; Dyskinesia, Drug-Induced; Extrapyramidal Tracts; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
[New psychopharmacologic alternatives in treatment of schizophrenia].
Topics: Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Piperidines; Psychotropic Drugs; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Psychomotor impairment and cognitive disturbances induced by neuroleptics.
Topics: Antipsychotic Agents; Attention; Chlorpromazine; Cognition Disorders; Eye Movements; Humans; Neurologic Examination; Neuropsychological Tests; Psychomotor Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1994 |
Preclinical findings with new antipsychotic agents: what makes them atypical?
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Humans; Receptors, Dopamine D2; Receptors, Neurotransmitter; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1994 |
Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride.
Topics: Antipsychotic Agents; Arousal; Cognition; Dyskinesia, Drug-Induced; Humans; Motivation; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1994 |
[Involvement of sigma receptors in schizophrenic syndromes. Pathophysiological approach].
Topics: Antipsychotic Agents; Carbazoles; Hippocampus; Humans; Piperidines; Psychotropic Drugs; Pyrimidines; Receptors, sigma; Remoxipride; Schizophrenia; Thalamus | 1993 |
Use of atypical neuroleptics in child and adolescent psychiatry.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Child; Child Development Disorders, Pervasive; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Remoxipride; Risperidone; Schizophrenia; Treatment Outcome | 1998 |
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Monoamines and schizophrenia.
Topics: Antipsychotic Agents; Benzamides; Brain; Dopamine; Humans; Neurotransmitter Agents; Norepinephrine; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Neurotransmitter; Remoxipride; Schizophrenia; Schizophrenic Psychology; Serotonin | 1990 |
Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.
Topics: Animals; Antipsychotic Agents; Benzamides; Humans; Remoxipride; Schizophrenia | 1990 |
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.
Topics: Antipsychotic Agents; Benzamides; Carbazoles; Carbolines; Drug Design; Female; Humans; Isoquinolines; Male; Piperazines; Pyridines; Pyrimidines; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, Serotonin; Receptors, sigma; Remoxipride; Schizophrenia; Spiro Compounds | 1989 |
43 trial(s) available for remoxipride and Schizophrenia
Article | Year |
---|---|
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1995 |
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
Topics: Adolescent; Adult; Australia; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Remoxipride; Schizophrenia; Schizophrenic Psychology; Thioridazine | 1994 |
Clinical action of remoxipride.
Topics: Double-Blind Method; Haloperidol; Humans; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia.
Topics: Adult; Basal Ganglia Diseases; Clozapine; Cognition; Double-Blind Method; Drug Tolerance; Emotions; Female; Haloperidol; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Tolerability of remoxipride in the long term treatment of schizophrenia. An overview.
Topics: Body Weight; Double-Blind Method; Female; Humans; Male; Prolactin; Remoxipride; Schizophrenia | 1993 |
A long-term study of remoxipride in chronic schizophrenic patients.
Topics: Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Remoxipride; Schizophrenia | 1993 |
Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Quality of Life; Remoxipride; Schizophrenia | 1997 |
The treatment of negative symptoms: a clinical and methodological study.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1999 |
Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Olanzapine; Pirenzepine; Remoxipride; Retention, Psychology; Retrospective Studies; Risperidone; Schizophrenia; Time Factors | 1999 |
A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Benzamides; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Remoxipride; Schizophrenia | 1992 |
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Haloperidol; Humans; Psychiatric Status Rating Scales; Recurrence; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1992 |
A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia | 1991 |
Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1991 |
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Biological Availability; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remoxipride; Schizophrenia | 1990 |
Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remoxipride; Schizophrenia | 1990 |
Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzamides; Capsules; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Prolactin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prolactin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Chlorpromazine; Clonazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Psychometrics; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology; Thioridazine | 1990 |
A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Experiences of long-term treatment with remoxipride: efficacy and tolerability.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Overdose; Female; Haloperidol; Hemodynamics; Humans; Long-Term Care; Male; Prolactin; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Pharmacokinetics of remoxipride in elderly psychotic patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzamides; Delayed-Action Preparations; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neurocognitive Disorders; Psychotic Disorders; Remoxipride; Schizophrenia | 1990 |
Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Benzamides; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Cognitive disturbances in neuroleptic therapy.
Topics: Adult; Antipsychotic Agents; Benzamides; Cognition Disorders; Double-Blind Method; Haloperidol; Humans; Intelligence; Neuropsychological Tests; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzamides; Canada; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group.
Topics: Adult; Benzamides; Double-Blind Method; Female; Haloperidol; Humans; Male; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Schizophrenia | 1990 |
Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzamides; Cognition; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Psychomotor Performance; Remoxipride; Schizophrenia; Schizophrenic Psychology; Time Factors | 1989 |
An open multicentre study of the treatment of florid schizophrenia with remoxipride.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1985 |
Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity.
Topics: Adult; Basal Ganglia Diseases; Benzamides; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Prolactin; Remoxipride; Schizophrenia | 1986 |
Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia.
Topics: Benzamides; Clinical Trials as Topic; Humans; Remoxipride; Schizophrenia | 1987 |
A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
Topics: Acute Disease; Adult; Aged; Benzamides; Double-Blind Method; Female; Humans; Male; Middle Aged; Remoxipride; Schizophrenia; Sleep Stages; Thioridazine | 1988 |
17 other study(ies) available for remoxipride and Schizophrenia
Article | Year |
---|---|
Adverse reaction reporting and new antipsychotics.
Topics: Agranulocytosis; Anemia, Aplastic; Antipsychotic Agents; Clozapine; Drug Monitoring; Humans; Isoxazoles; Neutropenia; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
Risperidone and remoxipride for schizophrenia.
Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
Remoxipride in the treatment of psychoses.
Topics: Adult; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine D2; Remoxipride; Retrospective Studies; Schizophrenia | 1994 |
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.
Topics: Analysis of Variance; Animals; Autoradiography; Benzamides; Benzazepines; Cerebral Cortex; Clozapine; Haloperidol; Iodine Radioisotopes; Kinetics; Macaca mulatta; Motor Cortex; Prefrontal Cortex; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Schizophrenia; Somatosensory Cortex; Temporal Lobe; Tritium; Visual Cortex | 1994 |
Disposition of remoxipride in Chinese schizophrenic patients.
Topics: Adult; Antipsychotic Agents; China; Chronic Disease; Humans; Male; Middle Aged; Remoxipride; Schizophrenia | 1996 |
[Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Remoxipride; Schizophrenia; Sex Factors; Sulpiride | 1996 |
Preclinical and clinical properties of the atypical antipsychotic drug remoxipride.
Topics: Animals; Antipsychotic Agents; Benzamides; Humans; Receptors, Dopamine; Remoxipride; Schizophrenia | 1992 |
New pharmaceutical strategies devised in effort to treat schizophrenia effectively with less risk.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzamides; Forecasting; Humans; Remoxipride; Schizophrenia | 1990 |
Tolerability and pharmacokinetics of remoxipride after intramuscular administration.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
Distribution of remoxipride to the human brain and central D2-dopamine receptor binding examined in vivo by PET.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzamides; Brain; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections, Intravenous; Male; Psychiatric Status Rating Scales; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Salicylamides; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1990 |
EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
Topics: Adult; Antipsychotic Agents; Behavior; Benzamides; Brain Mapping; Electroencephalography; Female; Hallucinations; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1990 |
An open study of remoxipride, a benzamide derivative, in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzamides; Brief Psychiatric Rating Scale; Humans; Remoxipride; Schizophrenia | 1985 |
Remoxipride in schizophrenia: effects on plasma prolactin.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Female; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia | 1985 |
An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.
Topics: Adult; Antipsychotic Agents; Benzamides; Drug Evaluation; Female; Humans; Male; Middle Aged; Remoxipride; Schizophrenia | 1986 |
Remoxipride in schizophrenia. A preliminary report.
Topics: Adult; Antipsychotic Agents; Benzamides; Female; Homovanillic Acid; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Remoxipride; Schizophrenia; Schizophrenic Psychology | 1986 |
Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
Topics: Adult; Antipsychotic Agents; Benzamides; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Half-Life; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Schizophrenia | 1987 |